Explorer les evidences

0,64 %Among HIV-positive patients aged 31–40 years in the study, the prevalence of HIV/HBV/HCV triple infection was 0.64%.

Nigeriahépatite B · hépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

5,79 %The overall prevalence of transfusion transmissible infections over the 6-year period for all donors at LUTH was 5.79% for HBV.

Nigeriahépatite Bpublié 2021West African journal of medicinePubMeddocument de 7 observations

6,77 log IU/mlOf the 81 HBsAg-positive samples, 27 had detectable HBV DNA by real-time PCR with mean viral loads of 6.77 log IU/ml.

Nigeriahépatite Bpublié 2019Antiviral therapyPubMeddocument de 4 observations

4,8 %The prevalence of HBV infection using HBsAg was 4.8% among HIV-naïve children in Lagos.

Nigeriahépatite B · VIH/sidapublié 2020PloS onePubMeddocument de 4 observations

57,8 %The HBV vaccination completion rate was 57.8% among participants aged 35–39 years in Lagos state, Nigeria.

Nigeriahépatite Bobservé June 2021 to June 2024publié 2026PloS onePubMeddocument de 12 observations

6,43 %The prevalence of HIV/HBV co-infection among HIV-positive patients attending three major hospitals in the Federal Capital Territory, Nigeria was 6.43%.

Nigeriahépatite B · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

3,2 %Viremic HDV prevalence rates ranged from 3.2% to 16% among HBV-infected individuals in Nigeria, as determined by RNA-based testing.

Nigeriahépatite B · hepatitis D viruspublié 2024VirusesPubMeddocument de 7 observations

4,47 %Among the 134 participants enrolled, 6 (4.47%) tested positive for hepatitis B.

Nigeriahépatite Bpublié 2025BMC pregnancy and childbirthPubMeddocument de 7 observations

Findings from our study show an intermediate level of hepatitis B endemicity in the study area.

Nigeriahépatite Bpublié 2022Journal of immunoassay & immunochemistryPubMeddocument de 5 observations